Search for: "Health One Pharmaceuticals, Inc." Results 1 - 20 of 1,476
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 May 2024, 1:07 pm by John Ross
Health insurance at one Georgia sheriff's office doesn't cover sex changes. [read post]
1 May 2024, 1:18 pm by Melissa Tremblay
Teva Pharmaceuticals, an AKS-based FCA case involving speaker programs sponsored by drug manufacturers, the U.S. [read post]
24 Apr 2024, 4:52 am by Erica Blachman Hitchings
According to a recent press release, the Department of Justice has filed a Complaint against New York-based Regeneron Pharmaceuticals Inc. [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
Chelation therapy is often touted as one way to remove heavy metals from the body. [read post]
23 Jan 2024, 9:01 pm by renholding
The $1 billion settlement – approved by the Southern District of New York on September 8, 2023 – is one of the Top 20 largest of all time. [read post]
19 Jan 2024, 4:00 am by Alan Macek
Whereas [Biogen Canada Inc v Taro Pharmaceuticals Inc, 2020 FC 621] suggests that something more than a mere unity of invention objection from the patent examiner is required in order for the divisional application to constitute a forced divisional application. [245] The preferred approach is an informed middle ground. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
2 Jan 2024, 12:56 pm by Kevin LaCroix
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
20 Dec 2023, 2:50 pm by Cynthia Marcotte Stamer
One reporting manager was transferred, received a reduction in pay, and was subsequently terminated for standing up against harassment. [read post]
19 Dec 2023, 4:48 pm by Cynthia Marcotte Stamer
An initiating party that has received a notification from a certified IDR entity that a dispute initiated before August 3, 2023 was improperly batched will have one opportunity to resubmit the improperly batched items and services for reconsideration within 10 business days of being notified by the certified IDR entity, provided that the initiating party’s 4-business-day period to resubmit the batched dispute expired between August 3 and August 9, 2023. [read post]
8 Dec 2023, 10:02 am by Cynthia Marcotte Stamer
According to the report, on March 30, 2021, LAFOURCHE  learned that an unauthorized individual obtained access to one of its owners’ email accounts through a phishing attack. [read post]
28 Nov 2023, 5:24 am by Guest Author
 Levine, 555 U.S. 555 (2009) Mutual Pharmaceutical Co., Inc. v. [read post]